ADVERTISEMENT
OUTSPOKEN ONCOLOGY
Episode 42: Updates and Controversies in CML With Matt Kalaycio
05/03/2022
Matt Kalaycio, MD, Cleveland Clinic, simplifies initial therapy and monitoring decisions for CML, financial implications for patients treated with TKIs, and treatment choices dictated by payers for patients with specific characteristics.
Dr Nabhan and Dr Kalaycio have no relevant financial disclosures.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Current Issue
June 2024
Volume 10
Issue 3
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Subscribe
Journal of Clinical Pathways Newsletter
Advertisement
Advertisement
Advertisement
Recent Stories
Advertisement